AMGNUSNASDAQ / NYSE · United States
AMGEN INC.
465.67USD-0.30%close 2026-11-13
Daily candles · 12 months
AMGN · 1DPerformance
1W
+1.1%1M
+7.3%3M
+11.0%6M
+42.7%YTD
+42.3%1Y
+38.3%52W low 312.39high 483.99
-3.8% from the 52-week high.
Trend
- vs 20-day average
- Above by 2.2%
- vs 50-day average
- Above by 9.5%
- vs 200-day average
- Above by 22.2%
- ATR (14d)
- 2.69%
- 10-day range
- 7.9%
- Volume vs 20-day avg
- 0.78×
Position size
- Risk per share
- 18.82 USD
- Shares
- 5
- Position value
- 2,328.35 USD
- % of account
- 23.3%
- Risk amount
- 94.1 USD
- 1R target
- 484.49
- 2R target
- 503.31
- 3R target
- 522.13
Fundamentals and earnings
- Market cap
- 251.89B
- P/E (trailing)
- 27.0
- P/E (forward)
- 18.6
- EPS (TTM / next yr)
- 17.25 / 25.06
- Dividend yield
- 2.13%
- Earnings date
- Feb 2, 2027 (est.)
Listing
- Ticker
- AMGN US
- Yahoo / TradingView
- AMGN · NASDAQ:AMGN
- Keyword
- GDS
- Mapped to
- GDS HOLDINGS LTD. (9698)9698 HK
Headlines
- Amgen's new drug could mean fewer shots for obesity patientsTheStreet · 5d ago
- Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today24/7 Wall St. · 6d ago
- 5 Worst Dow Stocks To Buy According to AnalystsInsider Monkey · 6d ago
- Top 3 Biotech Stocks To Watch In November 2026Simply Wall St. · 7d ago
- Is Eli Lilly Stock Worth More Than Its Competitors?Trefis · 8d ago
- Dow Jones Industrial Average ETF (DIA) Buys $96.4 Million More Goldman on Nov. 4GuruFocus.com · 8d ago
Prices and fundamentals from Yahoo Finance, delayed. Not financial advice.